Source: Health Canada shortage reports · Updated Jul 9, 2026
Cefazolin is in a widespread shortage in Canada. 1 of 13 reported products are affected, and Health Canada has designated this a Tier 3 (most serious) shortage. Manufacturers have not committed to a recovery date.
A cephalosporin antibiotic given by injection to treat bacterial infections such as skin and wound infections.
Products affected
1 / 13
In shortage since
Jun 2, 2025
Reports on file
48
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
CEFAZOLIN INJECTION, USP
20MG · SOLUTION · BAXTER CORPORATION
DIN 02496313 · since Jun 2, 2025, no end estimate · Shortage of an active ingredient.
Active shortage
CEFAZOLIN INJECTION, USP
20MG · SOLUTION · BAXTER CORPORATION
DIN 02496313 · since Jun 14, 2025, no end estimate · Shortage of an active ingredient.
Resolved
CEFAZOLIN FOR INJECTION USP
1G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308959 · ended May 4, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
CEFAZOLIN FOR INJECTION USP
10G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308967 · ended Apr 13, 2026 · Demand increase for the drug.
Resolved
CEFAZOLIN FOR INJECTION USP
1G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308959 · ended Feb 23, 2026 · Delay in shipping of the drug.
Resolved
CEFAZOLIN FOR INJECTION USP
10G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308967 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
Resolved
CEFAZOLIN FOR INJECTION, USP
100G · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02401029 · ended Nov 11, 2025 · Delay in shipping of the drug.
Resolved
CEFAZOLIN FOR INJECTION USP
500MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308932 · ended Jan 8, 2024 · Demand increase for the drug.
Discontinued
CEFAZOLIN FOR INJECTION
10G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02108135
Resolved
CEFAZOLIN FOR INJECTION
1G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02108127 · ended Aug 3, 2023 · Disruption of the manufacture of the drug.
Resolved
CEFAZOLIN FOR INJECTION
10G · POWDER FOR SOLUTION · STERIMAX INC
DIN 02437120 · ended Jun 30, 2023 · Delay in shipping of the drug.
Resolved
CEFAZOLIN FOR INJECTION
1G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02108127 · ended Jul 5, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 48 reports. All reports are on file with Health Canada.
What's happening
Cefazolin is currently affected by an active shortage report filed with Health Canada by BAXTER CORPORATION.
The reported cause is: shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
Health Canada has flagged this as a Tier 3 shortage, its most serious category, meaning the shortage has the greatest potential impact on the health system and alternatives are limited.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Cefazolin is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DB).
Recent changes
No changes recorded yet.
Common questions
What is Cefazolin used for?
A cephalosporin antibiotic given by injection to treat bacterial infections such as skin and wound infections.
When will Cefazolin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Cefazolin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.